Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $171,729 | 119 | 75.9% |
| Food and Beverage | $21,678 | 1,085 | 9.6% |
| Honoraria | $14,600 | 8 | 6.5% |
| Travel and Lodging | $12,499 | 79 | 5.5% |
| Consulting Fee | $5,175 | 1 | 2.3% |
| Education | $447.67 | 24 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $61,451 | 200 | $0 (2024) |
| Amgen Inc. | $56,199 | 122 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $26,402 | 40 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $19,708 | 54 | $0 (2024) |
| Orexigen Therapeutics, Inc. | $16,518 | 29 | $0 (2017) |
| IDORSIA PHARMACEUTICALS US INC | $13,307 | 26 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $6,454 | 10 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $5,870 | 18 | $0 (2022) |
| Esperion Therapeutics, Inc. | $5,371 | 54 | $0 (2021) |
| Allergan, Inc. | $3,705 | 89 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,304 | 153 | AstraZeneca Pharmaceuticals LP ($7,878) |
| 2023 | $16,356 | 124 | IDORSIA PHARMACEUTICALS US INC ($11,295) |
| 2022 | $9,823 | 128 | AstraZeneca Pharmaceuticals LP ($5,155) |
| 2021 | $19,325 | 175 | AstraZeneca Pharmaceuticals LP ($6,364) |
| 2020 | $15,279 | 104 | Amgen Inc. ($8,778) |
| 2019 | $52,874 | 212 | Amgen Inc. ($34,752) |
| 2018 | $55,718 | 208 | AstraZeneca Pharmaceuticals LP ($20,965) |
| 2017 | $44,449 | 212 | Orexigen Therapeutics, Inc. ($16,518) |
All Payment Transactions
1,316 individual payment records from CMS Open Payments — Page 1 of 53
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.37 | General |
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.96 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: DIABETES | ||||||
| 12/12/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Oncology | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: PAIN | ||||||
| 11/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: Cardiology | ||||||
| 11/20/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: CNS | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $2.10 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.95 | General |
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.58 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 460 | 714 | $142,026 | $60,854 |
| 2022 | 14 | 642 | 943 | $161,015 | $65,839 |
| 2021 | 7 | 397 | 679 | $135,145 | $56,295 |
| 2020 | 6 | 398 | 665 | $120,765 | $41,198 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 187 | 378 | $73,491 | $29,584 | 40.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 56 | 100 | $26,500 | $12,775 | 48.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 76 | 76 | $20,900 | $9,378 | 44.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 29 | 35 | $13,125 | $3,963 | 30.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 43 | 43 | $3,440 | $3,093 | 89.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 44 | 44 | $1,540 | $1,305 | 84.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 11 | 11 | $1,762 | $492.13 | 27.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 27 | $1,268 | $264.41 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 208 | 466 | $90,760 | $38,194 | 42.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 52 | 71 | $26,625 | $8,697 | 32.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 60 | 60 | $16,500 | $7,517 | 45.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 24 | 36 | $9,430 | $4,459 | 47.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 29 | 29 | $2,175 | $1,916 | 88.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 23 | $2,990 | $985.87 | 33.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 35 | 35 | $1,225 | $980.22 | 80.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 17 | 17 | $2,890 | $770.79 | 26.7% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 11 | 12 | $780.00 | $604.92 | 77.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 42 | 42 | $2,856 | $557.55 | 19.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 45 | 46 | $1,984 | $481.27 | 24.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 26 | 26 | $780.00 | $250.08 | 32.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 13 | 14 | $700.00 | $232.82 | 33.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 59 | 66 | $1,320 | $193.29 | 14.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 206 | 445 | $86,775 | $35,337 | 40.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 59 | 83 | $21,165 | $11,080 | 52.4% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 33 | 42 | $15,750 | $4,765 | 30.3% |
About Dr. James Petre, MD
Dr. James Petre, MD is a Family Medicine healthcare provider based in East Moline, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1619973989.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Petre, MD has received a total of $226,128 in payments from pharmaceutical and medical device companies, with $12,304 received in 2024. These payments were reported across 1,316 transactions from 61 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($171,729).
As a Medicare-enrolled provider, Petre has provided services to 1,897 Medicare beneficiaries, totaling 3,001 services with total Medicare billing of $224,186. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location East Moline, IL
- Active Since 06/22/2005
- Last Updated 09/23/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1619973989
Products in Payments
- FARXIGA (Drug) $57,651
- Prolia (Biological) $37,286
- PRALUENT ALIROCUMAB INJECTION (Biological) $32,802
- INVOKANA (Drug) $19,458
- EVENITY (Biological) $17,839
- CONTRAVE (Drug) $16,547
- QUVIVIQ (Drug) $13,307
- PRALUENT (Drug) $5,705
- NEXLIZET (Drug) $3,245
- UBRELVY (Drug) $3,048
- BYDUREON (Drug) $2,488
- NEXLETOL (Drug) $2,126
- JARDIANCE (Drug) $947.84
- Ozempic (Drug) $677.38
- Repatha (Biological) $647.74
- QULIPTA (Drug) $474.45
- VRAYLAR (Drug) $408.15
- LINZESS (Drug) $383.05
- ELIQUIS (Drug) $352.91
- CHANTIX (Drug) $314.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in East Moline
Dr. Nicholas Petre, Md, MD
Family Medicine — Payments: $7,388
Dr. Nancy Short, Md, MD
Family Medicine — Payments: $2,158
Dr. Anuradha Ranganath, M.d, M.D
Family Medicine — Payments: $1,978
Anne Petre, Md, MD
Family Medicine — Payments: $428.96